Target intelligence / Profile preview

Paired-like homeodomain transcription factor LEUTX (LEUTX)

Target
LEUTX
Molecular classification
Transcription factor, Homeodomain-containing protein, PRD-like homeobox protein
01

Overview

Paired-like homeodomain transcription factor LEUTX (LEUTX) is a PRD-like homeobox gene encoding a transcription factor that is expressed almost exclusively in human embryos during preimplantation development, specifically between the 4- and 8-cell stages[3][2][7]. LEUTX plays a crucial role in embryo genome activation by acting as a transcriptional activator of numerous genes necessary for the transition from maternal- to embryonic-controlled gene expression[2][3][4]. It binds to a specific DNA motif (TAATCC), and through interactions with histone acetyltransferases such as EP300 and CBP, via its 9 amino acid transactivation domain (9aaTAD), it enhances chromatin accessibility and drives expression of downstream targets[2]. LEUTX is essential for initiating the gene regulatory cascades in early human development, but after the 8-cell stage, its expression is silenced and it is not known to function in adult tissues. There is no evidence that LEUTX is a therapeutic target or that it is involved in disease states outside of its critical embryonic role[3][2][4][5][6][7].

Other names
Leucine twenty homeoboxPRD-like homeobox transcription factor LEUTXPaired-like homeobox transcription factor LEUTXPaired-like homeodomain transcription factor LEUTXPutative leucine-twenty homeoboxArginine-fifty homeobox-like pseudogene
02

Mechanism of action

Not applicable (no drugs targeting LEUTX. Its mechanism as a transcription factor involves binding specific DNA motifs and activating gene expression during embryonic genome activation[1][2][4].)

03

Biological functions

Embryo genome activation (EGA)Transcriptional activation during preimplantation developmentEnhancer binding and regulation of gene expression in early embryosRegulation of genes linked to preimplantation development, e.g., DPPA3, ZNF280A
04

Disease associations

Other (No direct association with common human diseases like cancer, inflammation, neurodegenerative, cardiovascular, or infection has been established. Primary role is in embryogenesis[3][2][5].)
05

Safety considerations

Not applicable (no therapies or interventions targeting LEUTX; it is not expressed or functional outside very early embryonic stages[2][3].)
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Paired-like homeodomain transcription factor LEUTX (LEUTX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paired-like homeodomain transcription factor LEUTX (LEUTX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call